196 related articles for article (PubMed ID: 2416203)
1. Foot-and-mouth disease and its antigens.
Bachrach HL
Adv Exp Med Biol; 1985; 185():27-46. PubMed ID: 2416203
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
[TBL] [Abstract][Full Text] [Related]
3. Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus.
Moore DM; Vakharia VN; Morgan DO
Virus Res; 1989 Dec; 14(4):281-95. PubMed ID: 2483013
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
5. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.
Robertson BH; Morgan DO; Moore DM
Virus Res; 1984 Sep; 1(6):489-500. PubMed ID: 6085200
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
[TBL] [Abstract][Full Text] [Related]
7. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.
Stave JW; Card JL; Morgan DO; Vakharia VN
Virology; 1988 Jan; 162(1):21-9. PubMed ID: 2827379
[TBL] [Abstract][Full Text] [Related]
8. Antigenic variation among foot-and-mouth disease virus type A field isolates of 1997-1999 from Iran.
Marquardt O; Freiberg B
Vet Microbiol; 2000 Jun; 74(4):377-86. PubMed ID: 10831859
[TBL] [Abstract][Full Text] [Related]
9. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR].
Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn
Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961
[TBL] [Abstract][Full Text] [Related]
10. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
Stave JW; Card JL; Morgan DO
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
[TBL] [Abstract][Full Text] [Related]
11. Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP.
Bachrach HL; Morgan DO; McKercher PD; Moore DM; Robertson BH
Vet Microbiol; 1982 May; 7(2):85-96. PubMed ID: 6287701
[TBL] [Abstract][Full Text] [Related]
12. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
[TBL] [Abstract][Full Text] [Related]
13. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.
Baxt B; Vakharia V; Moore DM; Franke AJ; Morgan DO
J Virol; 1989 May; 63(5):2143-51. PubMed ID: 2467993
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
[TBL] [Abstract][Full Text] [Related]
15. Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes.
Saiz JC; Gonzalez MJ; Morgan DO; Card JL; Sobrino F; Moore DM
Virus Res; 1989 May; 13(1):45-60. PubMed ID: 2473578
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
17. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
[TBL] [Abstract][Full Text] [Related]
18. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
Krebs O; Ahl R; Straub OC; Marquardt O
Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
[TBL] [Abstract][Full Text] [Related]
19. The structure and antigenicity of a type C foot-and-mouth disease virus.
Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
[TBL] [Abstract][Full Text] [Related]
20. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.
Saiz JC; Gonzalez MJ; Borca MV; Sobrino F; Moore DM
J Virol; 1991 May; 65(5):2518-24. PubMed ID: 1707983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
